OR WAIT 15 SECS
FORT LAUDERDALE, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- A major full-service, global contract research organization (CRO) has expanded its existing partnership with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the terms of a new $7.8 million multi-year agreement, the CRO will utilize OmniComm’s TrialOne system to ensure regulatory compliance and bring greater operational efficiency, speed and quality to the clinical research process within its clinics.
The CRO will use TrialOne to implement a number of automated clinical trial processes across multiple clinics, including the recruitment and screening of subject participants, study design and the collection, analysis and reporting of data.
“We’re excited to continue building our partnership with this leading CRO,” said Kuno van der Post, Ph.D., chief commercial officer at OmniComm. “We are very proud to have earned their trust for increased business and commitment. It is a pleasure to work with a company that shares our passion for problem solving for clients and seeks robust, scalable and innovative solutions to help meet expectations.”
TrialOne is a browser-based Bedside Data Collection technology specifically designed to automate the workflows and processes within early phase research clinics. As the market-leading early phase research clinical eSource system, TrialOne addresses the following needs of this CRO:
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. With an extensive global experience from more than 6,000 clinical trials, OmniComm provides comprehensive solutions for clinical research. Please visit www.omnicomm.com for more information.
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact InfoKuno van der Post, Ph.D. OmniComm Systems, Inc. +1.954.473.1254KvanderPost@omnicomm.com